Dominant T cell receptor rearrangements in interleukin 2 expanded lymphocytes from rheumatoid nodules suggest antigen driven T cell activation in situ

J Rheumatol. 1997 Sep;24(9):1685-9.

Abstract

Objective: To study at a molecular level the clonality of interleukin 2 (IL-2) expanded T cell lines derived from rheumatoid nodules. Such cell lines were reported in earlier studies with flow cytometry and antiidiotypic monoclonal antibodies (MAb) to be obligoclonal.

Methods: T cell lines were derived from rheumatoid nodules in 2 patients with rheumatoid arthritis (RA) and expanded in medium containing IL-2. Clonality was assessed by flow cytometry and T cell receptor (TCR) idiotype specific Mab and by polymerase chain reaction with primers for V alpha and V beta gene families. Sequence analysis was performed in selected cell lines.

Results: In one patient, one cell line was identified with marked overexpression of V alpha 2 cells. Eleven V alpha 2 CDR3 sequences were derived from this cell line: 8 of these clones had an identical CDR3 sequence and one other clone showed a related sequence. Five cell lines derived from a second patient displayed a marked clonal bias to V beta 8 cells. One cell line with strong V beta 8 expression was chosen for further sequence analysis. Twelve V beta 8 sequences were obtained; 11 showed identical CDR3 sequences.

Conclusion: Molecular analysis of TCR rearrangements in IL-2 expanded T cell lines from rheumatoid nodules strongly suggests that in situ T cell activation is related to classical antigen induced immune activation.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Arthritis, Rheumatoid / complications
  • Cell Line
  • Clone Cells / immunology
  • DNA Primers / chemistry
  • Flow Cytometry
  • Gene Rearrangement, alpha-Chain T-Cell Antigen Receptor / genetics*
  • Gene Rearrangement, beta-Chain T-Cell Antigen Receptor / genetics*
  • Humans
  • Interleukin-2 / pharmacology*
  • Lymphocyte Activation* / drug effects
  • Lymphocyte Activation* / genetics
  • Male
  • Polymerase Chain Reaction
  • Receptors, Antigen, T-Cell, alpha-beta / drug effects
  • Receptors, Antigen, T-Cell, alpha-beta / genetics*
  • Receptors, Antigen, T-Cell, alpha-beta / immunology
  • Rheumatoid Nodule / immunology*
  • T-Lymphocytes / immunology*

Substances

  • DNA Primers
  • Interleukin-2
  • Receptors, Antigen, T-Cell, alpha-beta